Erratum to ‘MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host’ [Cancer Lett. 109 (1996), 15–21]
- 1 May 1997
- journal article
- correction
- Published by Elsevier in Cancer Letters
- Vol. 115 (1) , 121-127
- https://doi.org/10.1016/s0304-3835(97)04754-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.The Journal of Experimental Medicine, 1994
- Chemistry and functional role of the invariant chainCurrent Opinion in Immunology, 1992
- Expression of intercellular adhesion molecule‐1 (ICAM‐1) on renal‐cell cancer: Possible significance in host immune responsesInternational Journal of Cancer, 1990
- Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancerBritish Journal of Cancer, 1990
- Response of glioma cells to interferon‐gamma: increase in class II RNA, protein and mixed lymphocyte reaction‐stimulating abilityEuropean Journal of Immunology, 1985
- Antigen-Presenting Function of the MacrophageAnnual Review of Immunology, 1984
- Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigensCell, 1982
- Major histocompatibility complex-restricted antigen presentation to antigen-reactive T cells by B lymphocyte tumor cells.The Journal of Experimental Medicine, 1981
- Role of MHC Gene Products in Immune RegulationScience, 1981
- Idiopathic Regression of Metastases from Renal Cell CarcinomaJournal of Urology, 1977